Hereditary Leiomyomatosis and Renal Cell Carcinoma

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer [Phase 2]

  Phase 2 clinical trial evaluating the combination of Bevacizumab, Erlotinib, and Atezolizumab for advanced renal cell carcinoma. The study i…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

  Ongoing ClinicalTrials.gov study investigating the genetic causes and cancer predisposition in hereditary leiomyomatosis with renal cell car…

• CLINICAL_TRIALS trial_result · 2021-05-10
  Clinical Trial Update: A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer [Phase 2]

  A Phase II trial of the DNA methyltransferase inhibitor guadecitabine (SGI-110) in children and adults with wild-type GIST, paraganglioma, p…